Drug Class: Selective Beta-1 Adrenergic Receptor Blocker (Beta-Blocker) | Form: Oral Tablet | Manufacturer: Searle Pakistan | Prescription Status: Prescription Only (Rx) — DRAP Registered
What is Byscard 2.5mg Tablet?
Byscard 2.5mg contains Nebivolol Hydrochloride at a lower 2.5mg dose — specifically designed as the recommended starting strength for elderly patients (65 years and above) and those with mild to moderate kidney impairment who require blood pressure or heart failure treatment but need a more gradual, carefully titrated introduction to beta-blocker therapy. Like the 5mg strength, Nebivolol in Byscard 2.5mg combines highly selective beta-1 receptor blockade with a unique ability to release nitric oxide — relaxing and widening blood vessels in a way older beta-blockers cannot. Manufactured by Searle Pakistan, Byscard 2.5mg reduces the heart's workload gently and effectively — making it the preferred starting option for high blood pressure (ہائی بلڈ پریشر) and stable chronic heart failure (دل کی دائمی کمزوری) in patients who are more sensitive to cardiovascular medicines.
What is Byscard 2.5mg Used For?
- Essential hypertension — first-line starting dose for blood pressure control in elderly patients and those with kidney impairment (ہائی بلڈ پریشر)
- Stable chronic heart failure — low starting dose for heart failure management in elderly patients before gradual dose titration upward (دل کی دائمی کمزوری)
- Dose titration starting point — used as the initial dose before stepping up to 5mg or higher based on tolerance and response under medical supervision
- Cardioprotection — reducing long-term cardiovascular strain in sensitive patients with established heart disease and hypertension
How Does Byscard 2.5mg Work?
Nebivolol at 2.5mg works through the same two complementary mechanisms as the higher strength — but with a gentler initial cardiovascular effect that improves tolerability in elderly and sensitive patients.
Beta-1 Selective Blockade: Nebivolol selectively blocks beta-1 adrenergic receptors in the heart — reducing the effect of adrenaline and stress hormones on the heart muscle. This slows the heart rate, reduces the force of each heartbeat, and lowers blood pressure — decreasing the overall oxygen demand of the heart and relieving strain on the cardiac muscle. At 2.5mg, this effect is introduced gradually — reducing the risk of excessive heart rate slowing or blood pressure drop that can occur with full starting doses in elderly patients.
Nitric Oxide-Mediated Vasodilation: Unlike older beta-blockers, Nebivolol stimulates the release of nitric oxide from blood vessel walls — causing them to relax and widen. This additional vasodilatory mechanism further lowers blood pressure and improves peripheral blood flow — reducing the cold hands and feet commonly associated with non-selective beta-blockers and making Byscard 2.5mg particularly well suited to elderly patients with peripheral circulation concerns.
Combined Effect: Together, gentle heart rate reduction and blood vessel relaxation reduce cardiac workload progressively — allowing the heart and blood vessels to adapt to beta-blocker therapy gradually, which is clinically important in elderly patients and those with reduced kidney clearance of medicines.
Dosage and Administration
⚠️ Always take exactly as prescribed by your doctor. Never stop Byscard suddenly without medical advice — abrupt discontinuation can cause dangerous rebound effects including worsening angina or serious heart rhythm disturbances.
| Indication | Usual Starting Dose | Frequency | Maintenance Dose |
|---|---|---|---|
| Hypertension (elderly / kidney impairment) | 2.5mg | Once daily | Up to 5mg once daily as tolerated |
| Stable Chronic Heart Failure (elderly) | 1.25mg | Once daily | Titrated slowly up to 10mg under supervision |
Critical Dosing Rules:
- Byscard 2.5mg is the recommended starting dose in patients aged 65 and above and those with mild to moderate kidney impairment — do not start at 5mg in these patients without specialist advice
- For heart failure, dose titration must always be slow and gradual — increasing only every 1 to 2 weeks under strict cardiology supervision
- Never stop Byscard suddenly — always reduce the dose gradually under your doctor's direct supervision to avoid rebound hypertension, worsening angina, or serious arrhythmia
- Heart rate must be monitored regularly throughout treatment — consult your doctor if resting heart rate falls below 55 beats per minute
- Elderly patients are more sensitive to dizziness and falls from blood pressure lowering — rise slowly from sitting or lying positions
How to Take:
- Swallow the tablet whole with a full glass of water
- May be taken with or without food — take consistently the same way each day
- Take at the same time each day for stable blood pressure and heart rate control
- If a dose is missed, take it as soon as remembered the same day — skip if it is the next day; never double the dose
Active Ingredients
| Ingredient | Strength per Tablet |
|---|---|
| Nebivolol Hydrochloride | 2.5mg |
Who Should NOT Take Byscard 2.5mg?
Do not take if you:
- Are allergic to Nebivolol or any ingredient in the tablet
- Have severe bradycardia — resting heart rate below 60 beats per minute
- Have second or third degree AV heart block — unless a pacemaker is fitted
- Have sick sinus syndrome
- Have severe liver disease
- Have decompensated heart failure requiring intravenous inotropic medicines
- Have severe peripheral arterial disease or severe Raynaud's syndrome
- Have untreated phaeochromocytoma (adrenal gland tumour)
- Have a history of severe bronchial asthma or severe COPD — risk of dangerous bronchospasm
- Are pregnant or breastfeeding
Always consult your doctor before taking Byscard 2.5mg if you have:
- Mild to moderate asthma or COPD (سانس کی بیماری) — use only under strict respiratory supervision with extreme caution
- Diabetes (ذیابیطس) — Nebivolol masks the fast heartbeat that warns of low blood sugar
- Mild to moderate kidney disease (گردے کی بیماری) — 2.5mg is the appropriate starting dose; monitor kidney function regularly
- Peripheral arterial disease or poor circulation in hands and feet
- Psoriasis — beta-blockers can worsen skin condition
- Thyroid disease — beta-blockers mask symptoms of an overactive thyroid
- Are scheduled for surgery or a dental procedure — inform your anaesthetist before any procedure
- Are taking medicines for depression, heart rhythm, or blood pressure — multiple interaction risks
Side Effects
Common Side Effects:
- Headache — usually mild and settles with continued use
- Fatigue or tiredness — heart rate reduction related; generally milder at 2.5mg than higher doses
- Dizziness or light-headedness — particularly when standing up quickly; elderly patients must take extra care to avoid falls
- Cold hands and feet — reduced peripheral circulation; less common with Nebivolol than older beta-blockers due to nitric oxide vasodilation
- Nausea or mild stomach discomfort
- Slow heartbeat (bradycardia) — monitor heart rate regularly throughout treatment
- Sleep disturbances or vivid dreams — beta-blocker class effect
Serious Side Effects — Stop Taking and Seek Medical Help Immediately:
- Severe bradycardia — very slow heart rate causing extreme dizziness, fainting, or loss of consciousness — particularly in elderly patients (دل کی دھڑکن کا بہت سست ہو جانا)
- Worsening heart failure — sudden breathlessness, rapid unexplained weight gain, severe ankle swelling — particularly during dose initiation (طبی ہنگامی صورتحال)
- Severe bronchospasm — sudden severe wheezing or difficulty breathing — dangerous in asthmatic patients; stop immediately and seek emergency care
- Severe hypotension — extreme dizziness, fainting, or collapse — elderly patients are particularly vulnerable
- AV heart block — fainting, extreme dizziness, or loss of consciousness — requires immediate cardiac evaluation
- Severe allergic reaction — swelling of face, lips, tongue or throat, difficulty breathing, widespread rash (یہ طبی ہنگامی صورتحال ہے)
- Rebound angina or hypertension — if Byscard is stopped suddenly without tapering; can trigger serious cardiovascular events in vulnerable patients
Drug Interactions
| Medicine / Substance | Possible Interaction |
|---|---|
| Calcium channel blockers — Verapamil / Diltiazem | Most critical — additive slowing of heart rate and AV conduction; dangerous bradycardia or complete heart block risk — avoid or use only under strict cardiology supervision |
| Other antiarrhythmics (e.g., Amiodarone, Digoxin) | Additive heart rate slowing — serious bradycardia and conduction disturbance risk; monitor heart rate and rhythm closely |
| Other antihypertensives | Additive blood pressure lowering — excessive hypotension risk particularly in elderly patients; monitor blood pressure carefully |
| Clonidine | Never stop Clonidine abruptly before Byscard — rebound hypertension risk; taper Clonidine only after Nebivolol is safely discontinued |
| MAO Inhibitors | Serious hypertensive crisis risk — avoid combination; stop MAO inhibitors at least 14 days before starting Nebivolol |
| Antidiabetic medicines (e.g., Insulin, Sulphonylureas) | Nebivolol masks fast heartbeat — a key hypoglycaemia warning sign; monitor blood sugar more carefully and regularly |
| Antidepressants — Fluoxetine / Paroxetine (SSRIs) | Significantly increase Nebivolol blood levels — risk of excessive bradycardia and side effects at even the 2.5mg dose |
| Anaesthetic agents | Additive cardiovascular depression — always inform your anaesthetist before any surgery or procedure |
| NSAIDs (e.g., Ibuprofen, Diclofenac) | Reduce blood pressure lowering effect of Nebivolol — avoid regular combined use |
| Alcohol (شراب) | Enhances blood pressure lowering and significantly increases dizziness and fall risk in elderly patients — avoid completely |
| Rifampicin | Reduces Nebivolol blood levels — may reduce its effectiveness; inform your doctor |
Storage Instructions
- Store below 25°C in a cool, dry place
- Protect from moisture and direct sunlight
- Keep in original blister pack until use
- Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
- Do not use after the expiry date printed on the pack
Frequently Asked Questions (FAQs)
Q: Why is Byscard 2.5mg prescribed instead of the 5mg strength? Byscard 2.5mg is the recommended starting dose for elderly patients and those with kidney impairment — allowing the body to adjust to beta-blocker therapy gradually before stepping up to higher doses if needed.
Q: Can I stop taking Byscard 2.5mg if I feel dizzy or unwell? Never stop Byscard suddenly — abrupt discontinuation can trigger dangerous rebound hypertension or worsening angina; always contact your doctor who will reduce the dose gradually if needed.
Q: Is Byscard 2.5mg safe for elderly patients with both hypertension and heart failure? Yes — 2.5mg is specifically the recommended starting dose for elderly patients with these conditions; however dose titration must always be slow and carefully supervised by a cardiologist.
Q: Will Byscard 2.5mg cause cold hands and feet like other beta-blockers? Nebivolol is less likely to cause cold extremities than older beta-blockers because it releases nitric oxide to keep blood vessels relaxed — though some patients may still notice mild changes in circulation at the extremities.
Medical Disclaimer: This information is for general awareness only and does not replace advice from your doctor or pharmacist. Byscard 2.5mg is a prescription cardiovascular medicine — never start, stop, or adjust the dose without consulting your healthcare provider. Regular heart rate and blood pressure monitoring is essential throughout treatment.